The findings demonstrate that increased Calbindin expression is associated with shorter progression-free survival and specific molecular alterations. CALB1 may therefore serve as an additional prognostic biomarker. We are pleased to have contributed to this research as collaborators and warmly congratulate the entire research team on this excellent publication!